Cell-cycle distribution of different cell compartments in normal versus reactive bone marrow: A frame of reference for the study of dysplastic hematopoiesis

Cytometry Part B - Clinical Cytometry

Volumn 80 B, Issue 6, 2011, Pages 354-361

  Matarraz, Sergio ^a   Fernandez, Carlos ^a   Albors, Manuel ^b   Teodosio, Cristina ^a   López, Antonio ^a   Jara Acevedo, María ^a   Cervero, Carlos ^c   Caballero, Gonzalo ^d   Gutierrez, Oliver ^e   Orfao, Alberto ^a  

^a Centro de Investigacion del Cancer   (Spain)

^b HOSPITAL JUAN CANALEJO   (Spain)

^c HOSPITAL VIRGEN DE LA LUZ   (Spain)

^d HOSPITAL SAN JORGE   (Spain)

^e HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

Author keywords

bone marrow; cell cycle; flow cytometry; proliferation index

Indexed keywords

CD11B ANTIGEN; CD34 ANTIGEN;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; BONE MARROW; BONE MARROW TUMOR; CELL COMPARTMENTALIZATION; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL EXPANSION; CELL MATURATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPENIA; EOSINOPHIL; ERYTHROCYTE; FEMALE; FLOW CYTOMETRY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE; MALE; MONOCYTE; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE NEOPLASM; NEUTROPHIL; NUCLEATED RED BLOOD CELL PRECURSOR; PRIORITY JOURNAL;

AGED; ANEMIA, IRON-DEFICIENCY; BONE MARROW CELLS; BONE MARROW DISEASES; CELL PROLIFERATION; CHROMOSOMES, HUMAN; FEMALE; FLOW CYTOMETRY; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; KARYOTYPING; MALE; MIDDLE AGED; REFERENCE VALUES; TIME FACTORS;

EID: 80054710983     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20605     Document Type: Article

References (31)

1. Nurse P,. A long twentieth century of the cell cycle and beyond. Cell 2000; 100: 71-78. (Pubitemid 30046296)
2. Doree M, Hunt T,. From Cdc2 to Cdk1: When did the cell cycle kinase join its cyclin partner? J Cell Sci 2002; 115: 2461-2464. (Pubitemid 34778063)
3. Murray AW,. Recycling the cell cycle: Cyclins revisited. Cell 2004; 116: 221-234. (Pubitemid 38167314)
4. Bloom J, Cross FR,. Multiple levels of cyclin specificity in cell-cycle control. Nat Rev Mol Cell Biol 2007; 8: 149-160. (Pubitemid 46432532)
5. Budirahardja Y, Gonczy P,. Coupling the cell cycle to development. Development 2009; 136: 2861-2872.
6. Stanger BZ,. Organ size determination and the limits of regulation. Cell Cycle 2008; 7: 318-324. (Pubitemid 351366495)
7. von Wangenheim KH, Peterson HP,. The role of cell differentiation in controlling cell multiplication and cancer. J Cancer Res Clin Oncol 2008; 134: 725-741.
8. Maddika S, Ande SR, Panigrahi S, Paranjothy T, Weglarczyk K, Zuse A, Eshraghi M, Manda KD, Wiechec E, Los M,. Cell survival, cell death and cell cycle pathways are interconnected: Implications for cancer therapy. Drug Resist Updat 2007; 10: 13-29. (Pubitemid 46636381)
9. Dor Y, Melton DA,. How important are adult stem cells for tissue maintenance? Cell Cycle 2004; 3: 1104-1106. (Pubitemid 40268622)
10. van Heemst D, den Reijer PM, Westendorp RG,. Ageing or cancer: A review on the role of caretakers and gatekeepers. Eur J Cancer 2007; 43: 2144-2152. (Pubitemid 47539121)
11. Wells AD,. Cyclin-dependent kinases: Molecular switches controlling anergy and potential therapeutic targets for tolerance. Semin Immunol 2007; 19: 173-179. (Pubitemid 46824072)
12. Montecucco C, Riccardi A, Traversi E, Giordano P, Mazzini G, Ascari E,. Proliferative activity of bone marrow cells in primary dysmyelopoietic (preleukemic) syndromes. Cancer 1983; 52: 1190-1195. (Pubitemid 13006453)
13. Montecucco C, Riccardi A, Traversi E, Danova M, Ucci G, Mazzini G, Giordano P,. Flow cytometric DNA content in myelodysplastic syndromes. Cytometry 1983; 4: 238-243. (Pubitemid 14158161)
14. Peters SW, Clark RE, Hoy TG, Jacobs A,. DNA content and cell cycle analysis of bone marrow cells in myelodysplastic syndromes (MDS). Br J Haematol 1986; 62: 239-245. (Pubitemid 16212073)
15. Vidriales MB, Orfao A, Lopez-Berges MC, Gonzalez M, Lopez-Macedo A, Ciudad J, Lopez A, Garcia MA, Hernandez J, Borrego D, et al. Prognostic value of S-phase cells in AML patients. Br J Haematol 1995; 89: 342-348.
16. San Miguel JF, Garcia-Sanz R, Gonzalez M, Moro MJ, Hernandez JM, Ortega F, Borrego D, Carnero M, Casanova F, Jimenez R, et al. A new staging system for multiple myeloma based on the number of S-phase plasma cells. Blood 1995; 85: 448-455.
17. Primo D, Flores J, Quijano S, Sanchez ML, Sarasquete ME, del Pino-Montes J, Gaarder PI, Gonzalez M, Orfao A,. Impact of BCR/ABL gene expression on the proliferative rate of different subpopulations of haematopoietic cells in chronic myeloid leukaemia. Br J Haematol 2006; 135: 43-51. (Pubitemid 44337661)
18. Matarraz S, Lopez A, Barrena S, Fernandez C, Jensen E, Flores J, Barcena P, Rasillo A, Sayagues JM, Sanchez ML, et al. The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursors. Leukemia 2008; 22: 1175-1183. (Pubitemid 351833785)
19. Matarraz S, Lopez A, Barrena S, Fernandez C, Jensen E, Flores-Montero J, Rasillo A, Sayagues JM, Sanchez ML, Barcena P, et al. Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: A pilot study on A series of 56 patients. Cytometry Part B: Clin Cytometry 2010; 78B: 154-168.
20. Swerts K, Van Roy N, Benoit Y, Laureys G, Philippe J,. DRAQ5: Improved flow cytometric DNA content analysis and minimal residual disease detection in childhood malignancies. Clin Chim Acta 2007; 379: 154-157. (Pubitemid 46366966)
21. Yuan CM, Douglas-Nikitin VK, Ahrens KP, Luchetta GR, Braylan RC, Yang L, DRAQ5-based DNA content analysis of hematolymphoid cell subpopulations discriminated by surface antigens and light scatter properties. Cytometry Part B: Clin Cytometry 2004; 58B: 47-52. (Pubitemid 38332720)
22. Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I,. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother 1996; 5: 213-226.
23. Alimena G, Billstrom R, Casalone R, Gallo E, Mitelman F, Pasquali F,. Cytogenetic pattern in leukemic cells of patients with constitutional chromosome anomalies. Cancer Genet Cytogenet 1985; 16: 207-218. (Pubitemid 15086995)
24. Mitelman F, editor. An International System for Human Cytogenetic Nomenclature. Basel, Switzerland: Karger; 1995.
25. Ketterling RP, Wyatt WA, VanWier SA, Law M, Hodnefield JM, Hanson CA, Dewald GW,. Primary myelodysplastic syndrome with normal cytogenetics: Utility of 'FISH panel testing' and M-FISH. Leuk Res 2002; 26: 235-240.
26. Teodosio CG-MA, Acevedo MJ, Muñoz LS, Ivan A-T, Nuñez R, Schwarrtz LB, Walls AF, Escribano L, Orfao A,. Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes. J Allergy Clin Immunol 2010; 125: 719-726, 726.e1-726.e4.
27. van Lochem EG, van der Velden VH, Wind HK, te Marvelde JG, Westerdaal NA, van Dongen JJ,. Immunophenotypic differentiation patterns of normal hematopoiesis in human bone marrow: Reference patterns for age-related changes and disease-induced shifts. Cytometry Part B: Clin Cytometry 2004; 60B: 1-13. (Pubitemid 38885703)
28. Pui CH, Crist WM, Look AT,. Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood 1990; 76: 1449-1463. (Pubitemid 20364007)
29. Quijano S, Lopez A, Rasillo A, Barrena S, Luz Sanchez M, Flores J, Fernandez C, Sayagues JM, Osuna CS, Fernandez N, et al. Association between the proliferative rate of neoplastic B cells, their maturation stage, and underlying cytogenetic abnormalities in B-cell chronic lymphoproliferative disorders: Analysis of a series of 432 patients. Blood 2008; 111: 5130-5141.
30. Orfao A, Ciudad J, Gonzalez M, San Miguel JF, Garcia AR, Lopez-Berges MC, Ramos F, Del Canizo MC, Rios A, Sanz M, et al. Prognostic value of S-phase white blood cell count in B-cell chronic lymphocytic leukemia. Leukemia 1992; 6: 47-51.
31. Rabkin CS, Janz S, Lash A, Coleman AE, Musaba E, Liotta L, Biggar RJ, Zhuang Z,. Monoclonal origin of multicentric Kaposi's sarcoma lesions. N Engl J Med 1997; 336: 988-993. (Pubitemid 27152784)